These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20299168

  • 1. [Interstitial pneumonia related to mesalamine].
    Lamsiah T, Moudden K, Baaj M, Hadri L.
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [Abstract] [Full Text] [Related]

  • 2. Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
    Moss AC, Cheifetz AS, Peppercorn MA.
    Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):290-3. PubMed ID: 16673009
    [Abstract] [Full Text] [Related]

  • 3. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
    Pérez C, Errázuriz I, Brockmann P, González S, Cofré C.
    Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
    [Abstract] [Full Text] [Related]

  • 4. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
    MMW Fortschr Med; 2004 Jun 10; 146(24):53. PubMed ID: 15366501
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov 10; 31(8):677-84. PubMed ID: 10730559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB, Klemt-Kropp M.
    Ned Tijdschr Geneeskd; 2011 Nov 10; 155(48):A3842. PubMed ID: 22152414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
    Raedler A, Behrens C, Bias P.
    Aliment Pharmacol Ther; 2004 Dec 10; 20(11-12):1353-63. PubMed ID: 15606398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB, Wedel MK, Xia S, Baker BF.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1403-13. PubMed ID: 16669955
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.